Future progress in improving cancer therapy can be expedited by better prioritization of new treatments for phase III evaluation. Historically, phase II trials have been key components in the ...
In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...
Serum Proteomic Fingerprinting Discriminates Between Clinical Stages and Predicts Disease Progression in Melanoma Patients Single-arm phase II trials may not be appropriate for testing cytostatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results